Report Highlights
The U.S. market for fertility clinic services is estimated to increase from $8.9 billion in 2023 to reach $16.8 billion by 2028, at a compound annual growth rate (CAGR) of 13.6% from 2023 through 2028.
Report Includes
- 37 tables
- An up-to-date overview and analysis of the U.S. market for fertility clinic services
- Analyses of the regional market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussion of the major growth drivers, industry-specific challenges, technology advancements, and the U.S. regulations and policies for fertility clinic services, which will shape the market as a basis for projecting demand in the next few years (2023-2028)
- Estimation of the actual market size and revenue forecast for the U.S. fertility clinics market, and corresponding market share analysis based on the type of service and end-user
- Discussion on cause of infertility and stages of fertility treatment along with the improved safety and efficacy of assisted reproductive technology
- Examination of the critical market characteristics of the fertility market, including technological developments, the value chain, market dynamics, and key market trends
- Insight into the recent structure of the industry, regulatory aspects, increasing investment on R&D activities, market development strategies, and company value share analysis
- Profile descriptions of the major fertility clinics corporations, including Boston IVF LLC, CNY Fertility Center, NYU Langone Fertility Center, Shady Grove Fertility (SGF), Weill Cornell Medicine, and the UCSF Center for Reproductive Health (CRH)
Report Scope
The scope of this report is broad and covers emerging trends in the U.S. fertility clinic market. No other geographic regions are covered. This report segments the U.S. fertility clinic market into assisted reproductive technology, diagnostic services and surgeries.
This report highlights the current and future market potential and provides a detailed analysis of the market’s drivers, challenges and opportunities. For market estimates, data has been provided for 2020, 2021 and 2022 (as the base year), along with a forecast for 2028. The report also analyzes the market shares of leading companies and includes profiles of the major players in the market. It also analyzes the impact of the COVID-19 pandemic on the U.S. fertility clinic market.
Report Synopsis
Report Metrics | Details | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2022 | ||||||||||||
Forecast period considered | 2023-2028 | ||||||||||||
Base year market size | $7.9 billion | ||||||||||||
Market size forecast | $16.8 billion | ||||||||||||
Growth rate | CAGR of 13.6% from 2023 to 2028 | ||||||||||||
Units considered | $ Millions | ||||||||||||
Segments covered | By Type of Service and End User | ||||||||||||
Key Market Drivers |
|
||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
- Increasing Prevalence of infertility.
- Single moms on the rise.
- Cultural shifts and increasing LGBT community.
- Reimbursement benefit trends.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The market for fertility clinics in the US should reach a value of $3.6 billion in 2017 and is expected to grow to $4.5 billion by 2022 at a compound annual growth rate (CAGR) of 4.6% for the period of 2017-2022.
Related Reports
Therapeutics for Women's Health: Technologies and Global Markets
The global therapeutics for women’s health technologies market is expected to grow from $61.5 billion in 2024 and is projected to reach $81.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2029.
Human Reproductive Technologies: Products and Global Markets
The global market for human reproductive technologies and products is valued at $16.1 billion in 2021 and is estimated to grow from $17.1 billion in 2022 to $24 billion in 2027 with a compound annual growth rate (CAGR) of 7% for the period of 2022-2027.
Pharmaceuticals for Women's Health: Global Markets
The global market for women’s health therapeutics should grow from $31.5 billion in 2019 to $41.2 billion by 2025, at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2025.
Drugs for Infertility: Global Markets to 2022
The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.
Recent Reports
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa
This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Global Colorectal Cancer Screening and Diagnostics Market
The global market for colorectal cancer screening and diagnostic testing services is estimated to increase from $40.0 billion in 2024 to reach $46.1 billion by 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029.
Medical Imaging: A BCC Research Outlook
The global market for medical imaging is expected to grow from $63.4 billion in 2024 and is projected to reach $82.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Top Trending Reports
2024 Semiconductor Manufacturing Research Review
This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from $810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More